5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 67.27▼ | 67.81▼ | 68.70▼ | 67.36▼ | 65.89▲ |
MA10 | 67.22▼ | 69.74▼ | 69.45▼ | 66.40▲ | 65.48▲ |
MA20 | 67.83▼ | 69.50▼ | 68.95▼ | 65.22▲ | 63.38▲ |
MA50 | 69.23▼ | 68.09▼ | 67.46▼ | 64.91▲ | 63.23▲ |
MA100 | 68.79▼ | 66.84▼ | 65.99▲ | 63.27▲ | 54.01▲ |
MA200 | 67.78▼ | 66.57▲ | 66.47▲ | 62.17▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.038▼ | -0.545▼ | -0.378▼ | 0.298▲ | 0.422▲ |
RSI | 38.579▼ | 34.766▼ | 40.221▼ | 52.340▲ | 55.016▲ |
STOCH | 34.556 | 13.689▼ | 33.907 | 63.898 | 50.736 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -60.241 | -41.816 |
CCI | -71.621 | -110.270▼ | -128.806▼ | 128.709▲ | 105.613▲ |
Saturday, September 13, 2025 10:36 AM
Belite Bio (BLTE) recently announced the successful completion of the Phase 3 DRAGON clinical trial, which significantly focuses on treating Stargardt disease type 1. The company's share price ...
|
Friday, September 12, 2025 05:12 AM
Tinlarebant has been granted Breakthrough Therapy, Fast Track, and Rare Pediatric Disease Designations in the U.S.; Orphan Drug Designation in the U.S., Europe, and Japan; and Pioneer Drug Designation ...
|
Monday, September 08, 2025 05:00 AM
Transaction led by RA Capital Management with participation from Eventide Asset Management, Marshall Wace, RTW Investments, Soleus Capital and Vestal Point Capital$125 million financing upfront with ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/09/25 | 69.60 | 73.80 | 65.90 | 66.80 | 194,853 |
12/09/25 | 68.50 | 69.90 | 67.20 | 69.48 | 66,204 |
11/09/25 | 66.63 | 69.30 | 66.00 | 68.55 | 52,143 |
10/09/25 | 65.50 | 66.585 | 65.30 | 66.27 | 28,232 |
09/09/25 | 66.50 | 68.00 | 65.68 | 65.68 | 22,519 |
08/09/25 | 69.69 | 69.69 | 67.1605 | 67.51 | 20,584 |
05/09/25 | 66.09 | 67.10 | 65.50 | 65.74 | 25,566 |
04/09/25 | 64.00 | 65.71 | 64.00 | 65.14 | 11,872 |
03/09/25 | 65.49 | 66.15 | 63.51 | 63.51 | 23,424 |
02/09/25 | 62.18 | 65.46 | 62.18 | 65.36 | 18,414 |
|
|
||||
|
|
||||
|
|